Clinical Trial Update: Combination of Nelmastobart and Capecitabine Therapy in Metastatic Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating the combination of nelmastobart and capecitabine in patients with recurrent or metastatic colorectal cancer; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Nelmastobart (nelmastobart)

Snippet

Sponsor: Korea University Anam Hospital | Conditions: Recurrent or Metastatic Colorectal Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING